Gå offline med appen Player FM !
Neurocrine wins FDA nod for 'sprinkle' Ingrezza, Moderna-Metagenomi deal ends, Emergent's layoffs [The good, the bad, the ugly]
Manage episode 416822148 series 2941835
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — Neurocrine wins FDA nod for 'sprinkle' Ingrezza formulation
The bad — Moderna, Metagenomi end gene editing collab
The ugly — Emergent announces layoffs, closes sites
62 episoder
Manage episode 416822148 series 2941835
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — Neurocrine wins FDA nod for 'sprinkle' Ingrezza formulation
The bad — Moderna, Metagenomi end gene editing collab
The ugly — Emergent announces layoffs, closes sites
62 episoder
すべてのエピソード
×Velkommen til Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.